Thomas Nösslinger

New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients

Detlef Haase, Ulrich Germing, Julie Schanz et al. · Blood · 2007 · 789 citations · Full text

Life Sciences, Genetics, Oncology +16

New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge

Julie Schanz, Heinz Tüchler, Françesc Solé et al. · Journal of Clinical Oncology · 2012 · 691 citations · Full text

Medicine, Hematology, Oncology +17

First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia

Barbara Eichhorst, Carsten Utoft Niemann, Arnon P. Kater et al. · New England Journal of Medicine · 2023 · 291 citations · Full text

Medicine, Hematology, Oncology +16

Predictive Role of Interphase Cytogenetics for Survival of Patients With Multiple Myeloma

Robert Königsberg, Niklas Zojer, Jutta Ackermann et al. · Journal of Clinical Oncology · 2000 · 182 citations

Life Sciences, Genetics, Hematology +17

Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS)

Ulrich Germing, Barbara Hildebrandt, Michael Pfeilstöcker et al. · Leukemia · 2005 · 161 citations

Medicine, Clinical Sciences, Risk Assessment +10